tryptophan has been researched along with Conus Medullaris Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leonard, AV; Thornton, E; Vink, R | 1 |
| Fodor, A; Karczag, I; Molnár, G; Szilágyi, A; Ujvárosi, I | 1 |
2 other study(ies) available for tryptophan and Conus Medullaris Syndrome
| Article | Year |
|---|---|
NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.
Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Inflammation; Neurokinin-1 Receptor Antagonists; Protease Inhibitors; Rabbits; Receptors, Neurokinin-1; Spinal Cord Compression; Substance P; Tryptophan | 2014 |
5-Hydroxyindoleacetic acid in cerebrospinal fluid.
Topics: Adult; Age Factors; Brain Diseases; Brain Stem; Depression; Epilepsy; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Middle Aged; Neurocognitive Disorders; Paralysis; Parkinson Disease; Probenecid; Spectrometry, Fluorescence; Spinal Cord Compression; Tabes Dorsalis; Tryptophan | 1973 |